Edition:
United States

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

558.00DKK
24 May 2017
Change (% chg)

kr.-2.00 (-0.36%)
Prev Close
kr.560.00
Open
kr.561.00
Day's High
kr.566.50
Day's Low
kr.557.00
Volume
427,209
Avg. Vol
284,548
52-wk High
kr.594.00
52-wk Low
kr.428.00

Latest Key Developments (Source: Significant Developments)

Coloplast Q2 revenue at DKK 3.88 BLN, in line with expectations
Wednesday, 3 May 2017 05:57am EDT 

May 3 (Reuters) - COLOPLAST ::H1 ORGANIC REVENUE GROWTH WAS 6%.RESOLVED THAT COLOPLAST WILL PAY AN INTERIM DIVIDEND OF DKK 4.50 PER SHARE FOR A DIVIDEND PAY-OUT OF DKK 955M.H1 REVENUE IN DKK WAS UP BY 5% TO DKK 7,636 MILLION."WE CONTINUE TO EXPECT ORGANIC REVENUE GROWTH OF 7-8% AT CONSTANT EXCHANGE RATES AND REPORTED GROWTH OF 7-8% IN DKK".BOARD HAS RESOLVED COLOPLAST WILL PAY INTERIM DIVIDEND OF DKK 4.50PER SHARE FOR DIVIDEND PAY-OUT OF DKK 955 MILLION.EBIT MARGIN GUIDANCE REMAINS AT 33-34% AT CONSTANT EXCHANGE RATES AND AT ABOUT 33% IN DKK.2016/17 CAPITAL EXPENDITURE IS STILL EXPECTED TO BE AROUND DKK 700M.CONTINUE TO EXPECT 2016/17 ORGANIC REVENUE GROWTH OF 7-8% AT CONSTANT EXCHANGE RATES AND REPORTED GROWTH OF 7-8% IN DKK.2016/17 EBIT MARGIN GUIDANCE REMAINS AT 33-34% AT CONSTANT EXCHANGE RATES AND AT ABOUT 33% IN DKK.H1 EBIT UP 8 PERCENT TO DKK 2.47 BILLION.COLOPLAST - FREE CASH FLOW WAS NEGATIVE AT DKK 648M, DKK 1,834M LESS THAN IN SAME PERIOD OF LAST YEAR.Q2 REVENUE DKK 3.88 BILLION (REUTERS POLL DKK 3.89 BILLION).Q2 EBIT DKK 1.25 BILLION (REUTERS POLL DKK 1.27 BILLION).  Full Article

Coloplast Q1 EBIT DKK 1.23 bln, in line with expectations
Wednesday, 1 Feb 2017 06:00am EST 

Coloplast A/S : Q1 organic revenue growth was 6 pct . Q1 revenue 3.76 billion Danish crowns ($545 million)(Reuters poll 3.76 billion crowns) . Q1 EBIT 1.23 billion crowns (Reuters poll 1.22 billion crowns) . Expects revenue growth of 7-8 pct at constant exchange rates and of 7-8 pct in Danish crowns in 2016/17 . Expects an EBIT margin of 33-34 pct, at constant exchange rates and of about 33 pct in Danish crownsin 2016/17 .2016/17 capital expenditure is expected to be about 700 million crowns.  Full Article

Coloplast Q3 EBIT DKK 1.20 billion, below estimates
Tuesday, 16 Aug 2016 06:03am EDT 

Coloplast : Q3 revenue 3.69 billion Danish crowns ($559.15 million) versus 3.72 billion crowns seen in Reuters poll . Q3 EBIT 1.20 billion crowns (Reuters poll 1.22 billion crowns) . Continues to expect organic revenue growth for 2015/16 of 7-8 pct at constant exchange rates and now of about 6 pct in Danish crowns from previously 6-7 pct . Continues to expect EBIT margin to be 33-34 pct at constant exchange rates and to be about 33 pct in Danish crowns for 2015/16 .2015/16 capital expenditure is still expected to be 600-700 million crowns; effective tax rate is still expected to be about 23 pct.  Full Article

Coloplast adjusts downwards 3-yr organic revenue growth outlook
Wednesday, 22 Jun 2016 07:12am EDT 

Coloplast A/S : Says Board approved new long-term financial guidance, spanning three years . Says new target for three years is organic revenue growth of 7-9 pct p.a. . Previous long-term guidance was organic revenue growth of 7-10 pct p.a. . Long-term financial guidance on EBIT-margin remains unchanged - EBIT-margin expansion of 1/2 - 1 percentage points p.a. . Says change in long-term organic revenue growth guidance is explained by challenging macroeconomic environment in emerging markets .Says financial guidance for 2015/16 is unchanged.  Full Article

Coloplast comments on FY 2015/16 outlook
Tuesday, 2 Feb 2016 06:01am EST 

Coloplast A/S:Expects revenue growth of 7-8 pct at constant exchange rates and of around 7 pct in Danish crowns in FY 2015/16.Sees an EBIT margin of 33-34 pct at constant exchange rates and of around 33 pct in Danish crowns in FY 2015/16.  Full Article

Coloplast A/S settles with US Department of Justice
Wednesday, 23 Dec 2015 01:00am EST 

Coloplast A/S:Settles with US Department of Justice.Will pay $3.1 million and legal costs​.Case between government and Coloplast is fully resolved.Amount is included in Coloplast's annual financial report, which was released on Nov 3​.  Full Article

Coloplast announces FY 2015-16 expectations
Tuesday, 3 Nov 2015 05:49am EST 

Coloplast A/S:Says for FY 2015-2016, expects organic revenue growth of 7-8 percent at constant exchange rates and 8-9 percent in Danish crowns.Says for FY 2015-2016, expects an EBIT margin of 33-34 percent, both at constant exchange rates and in Danish crowns.Says for FY 2015-2016, capital expenditure is expected to be around 700 million crowns.  Full Article

Ambu and Coloplast partner on product for urology market
Friday, 2 Oct 2015 06:43am EDT 

Ambu A/S:Announces partnership with Coloplast on visualization product for the urology market.Product is based on Ambu's videoscope technology, produced at Ambu's manufacturing site in Malaysia, and will be sold exclusively by Coloplast as of December.  Full Article

Coloplast A/S to cut 300 jobs in Denmark - Reuters
Tuesday, 15 Sep 2015 08:00pm EDT 

Coloplast A/S:Coloplast will cut 300 production jobs at two factories in Denmark over the next three years as part of a new strategy aimed at reducing the need to pilot the production of new products - Reuters.The two sites, Thisted and Mordrup, are so-called innovation factories where manufacturing of new products is tested before full-scale production is begun at Coloplast's factories abroad, mainly in Hungary and China - Reuters.The number of employees at the two Danish factories will be reduced to around 400 from around 700 over the next three years - Reuters.  Full Article

Coloplast keeps FY 2014/15 guidance
Tuesday, 11 Aug 2015 06:01am EDT 

Coloplast A/S:Says still expects 7 percent organic sales growth in FY 2014/15.Says still expects EBIT margin of about 32 percent in local currencies in FY 2014/2015.FY 2014/2015 EBIT margin 32.4 pct-Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Coloplast Q2 revenue at DKK 3.88 BLN, in line with expectations

* RESOLVED THAT COLOPLAST WILL PAY AN INTERIM DIVIDEND OF DKK 4.50 PER SHARE FOR A DIVIDEND PAY-OUT OF DKK 955M